D E Heiselman1, J Chapman, M Malik
1Department of Critical Care Medicine, Akron General Medical Center, OH 44307.
Famotidine, a histamine H2 antagonist, did not significantly alter hemodynamic parameters in stable, critically ill patients. This study found no significant differences compared to a saline placebo, suggesting its safety for hemodynamic stability in this population.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: